Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoQ10 and GPI 1485 in Early Parkinson's Disease
NCT00076492Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Jan 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing CoQ10, GPI 1485 and Placebo (3 arms). Primary endpoint: Change in Total Unified Parkinson's Disease Rating Scale Score at 12 months. Started Jan 2004; status: completed.
02
Drugs
coenzyme q10GPI-1485
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00076492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076492.